ColoFIT Home Collection Test

Collecting a sample for your Labcorp ColoFIT^TM Home Test is simple. If you’d like to see a video explaining the process, click here.

1.       When you are ready to collect your sample, register your kit online at ondemand.labcorp.com/register.

2.       Place all kit contents on a clean, dry surface.

3.       Place the collection paper inside toilet bowl on top of the water.

4.       Deposit stool sample on top of collection paper.

5.       Open green cap of the collection device by twisting and lifting the probe from the device.

6.       Scrape the surface of the fecal sample with the sample probe. Cover the grooved portion completely with stool sample.

7.       Close collection device by inserting the sample probe and green cap on tightly.

8.       Wrap the collection device in the absorbent pad and insert into the biohazard specimen bag.

9.       Place the sealed biohazard specimen bag into the blue kit box and close. Place the kit box into the USPS return pack. Remove the adhesive cover strip and seal the return pack closed.

10.   Place the postage paid return pack in your mailbox for mailing back to the lab. Mail the package within 24 hours of collection.

Full detailed instructions are included in the kit package.

The American Cancer Society recommends that people with average risk of CRC begin regular annual screening at age 45.

However, you may need to be screened earlier if you have:
• Inflammatory bowel diseases such as Crohn’s disease or ulcerative colitis
• Personal or family history of CRC or colorectal polyps
• Certain genetic conditions⁴

We encourage you to speak with your provider if you think you are at increased risk for CRC to discuss when to start screening, which test is right for you, and how often to get tested.

There are pros and cons for the different options used for screening.  If you are reluctant to get a screening colonoscopy but dedicated to protecting your health, an at-home fecal immunochemical test (FIT) may be a good alternative.  We encourage you to speak with your provider to determine which test is right for you.

While the Labcorp ColoFIT^TM Home Test can detect blood in feces, which can be found in a number of gastrointestinal (GI) disorders, including colorectal cancer.  It is not an official diagnosis. Speak to your healthcare provider as soon as possible if you receive a positive result. 

Advanced colorectal cancers may not cause noticeable symptoms, which makes early screening even more critical. Bleeding, especially from polyps and tumors, is intermittent, so blood is not always present in all stool samples. Repeat testing can increase the chances of determining if blood is present from a reoccurring problem. FIT should be repeated at least once a year when used as a screening tool for colorectal cancer screening. 

1. National Cancer Institute. Screening tests to detect colorectal cancer and polyps. National Cancer Institute website. Reviewed August 2, 2021. Accessed November 21, 2022. https://www.cancer.gov/types/colorectal/screening-fact-sheet

2. American Cancer Society. Colorectal Cancer Screening Tests. American Cancer Society website. Updated June 29, 2020. Accessed November 21, 2022. https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/screening-tests-used.html

3. U.S. Department of Health and Human Services. Get tested for colorectal cancer. U.S. Department of Health and Human Services website. Updated November 21, 2022. Accessed November 21, 2022. https://health.gov/myhealthfinder/doctor-visits/screening-tests/get-tested-colorectal-cancer

Visit the Labcorp OnDemand® website to browse and purchase laboratory tests and create your Labcorp Patient™ account to view your results. All Labcorp OnDemand testing requires an order from an authorized healthcare professional. For your convenience, Labcorp OnDemand has contracted with independent professional entities (collectively, Providers) to deliver healthcare provider services. Visit a Labcorp location for sample collection; or, if using an at-home collection kit, collect your sample yourself. We’ll let you know when your results are ready and can be accessed through your Labcorp Patient™ account.

Your results will be provided to you through our secure online portal to view or print. Results are also made available through a secure portal to the independent healthcare provider who placed your test order.  If you are accessing your results through your Labcorp Patient™ account, all users linked to the account will have access to all OnDemand test results. Results may also be provided to a local, state, and/or federal health authority; for example, many states require the testing laboratory and physician to report test results for certain communicable diseases, such as COVID-19, to local or state health departments.

If you have questions or comments regarding the Labcorp Notice of Privacy Practices, or have a complaint about our use or disclosure of your PHI or our privacy practices, please contact: privacyofficer@labcorp.com, call us at (877) 234-4722 (877-23-HIPAA) and ask for the Labcorp HIPAA Privacy Officer, or send a written request to: HIPAA Privacy Officer, Labcorp, 531 South Spring Street, Burlington, NC 27215. You also may file a complaint with the Secretary of the U.S. Department of Health and Human Services.

Your testing will be performed in a CLIA-certified clinical laboratory. Labcorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. Our labs perform regular quality assurance testing to ensure our results are accurate.

Because FIT explicitly detects the presence of blood, women should not take this test during or at the anticipated time of menstruation, as it may interfere with the accuracy of results. If you have an ongoing condition (such as diverticulitis or hemorrhoids) where blood can occasionally show up in the stool, this test may not be suitable for you. We encourage you to consult a healthcare provider to discuss which types of screening are recommended.